venous malformations

Relay Therapeutics Shares Positive Phase 2 Zovegalisib Data

CAMBRIDGE, Mass., May 19, 2026 Relay Therapeutics announced promising initial Phase 2 clinical data for zovegalisib, its investigational mutant-selective...

By cGxPwire Editor
May 20, 2026

Bio-Pharma

Palvella Reports Positive Phase 2 Data for QTORIN in Venous Malformations

WAYNE, Pa., May 15, 2026 Palvella Therapeutics announced new positive Phase 2 TOIVA trial data for QTORIN™ rapamycin in...

By cGxPwire Editor
May 16, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

venous malformations

Relay Therapeutics Shares Positive Phase 2 Zovegalisib Data

Palvella Reports Positive Phase 2 Data for QTORIN in Venous Malformations